- Home
- PMTS vs RVNC Comparison
PMTS vs RVNC Comparison
Compare PMTS & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- RVNC
- Stock Information
- Founded
- PMTS 2007
- RVNC 1999
- Country
- PMTS United States
- RVNC United States
- Employees
- PMTS N/A
- RVNC N/A
- Industry
- PMTS Finance Companies
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- PMTS Finance
- RVNC Health Care
- Exchange
- PMTS Nasdaq
- RVNC Nasdaq
- Market Cap
- PMTS 295.6M
- RVNC 546.4M
- IPO Year
- PMTS 2015
- RVNC 2014
- Fundamental
- Price
- PMTS $23.33
- RVNC $5.29
- Analyst Decision
- PMTS Strong Buy
- RVNC Buy
- Analyst Count
- PMTS 3
- RVNC 10
- Target Price
- PMTS $32.00
- RVNC $10.86
- AVG Volume (30 Days)
- PMTS 34.6K
- RVNC 1.3M
- Earning Date
- PMTS 11-05-2024
- RVNC 11-06-2024
- Dividend Yield
- PMTS N/A
- RVNC N/A
- EPS Growth
- PMTS N/A
- RVNC N/A
- EPS
- PMTS 1.52
- RVNC N/A
- Revenue
- PMTS $439,489,000.00
- RVNC $251,178,000.00
- Revenue This Year
- PMTS $7.13
- RVNC $20.36
- Revenue Next Year
- PMTS $5.39
- RVNC $31.66
- P/E Ratio
- PMTS $15.18
- RVNC N/A
- Revenue Growth
- PMTS N/A
- RVNC 40.23
- 52 Week Low
- PMTS $12.65
- RVNC $2.30
- 52 Week High
- PMTS $31.00
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- PMTS 37.21
- RVNC 44.50
- Support Level
- PMTS $23.01
- RVNC $5.10
- Resistance Level
- PMTS $24.35
- RVNC $5.43
- Average True Range (ATR)
- PMTS 0.63
- RVNC 0.17
- MACD
- PMTS -0.02
- RVNC 0.02
- Stochastic Oscillator
- PMTS 32.06
- RVNC 66.67
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.